BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37089789)

  • 1. Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson's Disease via Bioinformatics Analysis.
    Zhou Y; Li Z; Chi C; Li C; Yang M; Liu B
    Parkinsons Dis; 2023; 2023():6755569. PubMed ID: 37089789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
    Xin G; Niu J; Tian Q; Fu Y; Chen L; Yi T; Tian K; Sun X; Wang N; Wang J; Zhang H; Wang L
    PLoS One; 2023; 18(12):e0294984. PubMed ID: 38051734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
    Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S
    Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease.
    Li J; Sun Y; Chen J
    J Mol Neurosci; 2018 Aug; 65(4):527-535. PubMed ID: 30083784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Immune-Related Hub Genes in Parkinson's Disease.
    Chen L; Wang Y; Huang J; Hu B; Huang W
    Front Genet; 2022; 13():914645. PubMed ID: 35938039
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrative Analysis of Gene Expression and Regulatory Network Interaction Data Reveals the Protein Kinase C Family of Serine/Threonine Receptors as a Significant Druggable Target for Parkinson's Disease.
    Odumpatta R; Arumugam M
    J Mol Neurosci; 2021 Mar; 71(3):466-480. PubMed ID: 32728898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
    Su L; Wang C; Zheng C; Wei H; Song X
    BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel diagnostic biomarkers related to immune infiltration in Parkinson's disease by bioinformatics analysis.
    Zhang P; Zhao L; Li H; Shen J; Li H; Xing Y
    Front Neurosci; 2023; 17():1083928. PubMed ID: 36777638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
    Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
    Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
    Wang Y; Wang Z
    Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease.
    Zhang X; Feng S; Fan Y; Luo Y; Jin L; Li S
    Front Neurol; 2020; 11():810. PubMed ID: 32849243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease.
    Chatterjee P; Roy D; Bhattacharyya M; Bandyopadhyay S
    BMC Genomics; 2017 Sep; 18(1):721. PubMed ID: 28899360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Core Genes in Parkinson's Disease Using Bioinformatics Analysis.
    Quan W; Li J; Jin X; Liu L; Zhang Q; Qin Y; Pei X; Chen J
    Parkinsons Dis; 2021; 2021():1690341. PubMed ID: 34580608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis-related factors in the substantia nigra are associated with Parkinson's disease.
    Liu L; Cui Y; Chang YZ; Yu P
    Sci Rep; 2023 Sep; 13(1):15365. PubMed ID: 37717088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of potential common pathogenic mechanism for carotid atherosclerosis and Parkinson's disease.
    Wang Q; Xue Q
    Front Aging Neurosci; 2023; 15():1202952. PubMed ID: 37649719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson's Disease.
    Yin X; Wang M; Wang W; Chen T; Song G; Niu Y; Jiang Z; Gao Z; Wang Z
    Parkinsons Dis; 2022; 2022():2877728. PubMed ID: 36105301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.
    Peng X; Zhang Z; Mo Y; Liu J; Wang S; Liu H
    Onco Targets Ther; 2021; 14():3903-3919. PubMed ID: 34234459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.